JPRN-UMIN000022530已完成未知
Multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for prostate cancer - Multi-institutional study of HDR combined with EBRT for prostate cancer
kitasato univerisity0 个研究点目标入组 3,000 人开始时间: 2016年5月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
High-dose-rate brachytherapy combined with external beam radiotherapy was an effective and safe treatment for localized prostate cancer. Combination of long-term ADT was suggested to be necessary, even for HDR brachytherapy, and was useful in suppressing late toxicities. Meanwhile, pelvic irradiation was suggested to have an adverse effect on OS of our study population.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
2 期
A Study of Patients Receiving High-Dose Rate BrachytherapyEndometrial CancerBiliary CancerCervical CancerProstate CancerEsophageal CancerNCT00924027National Cancer Institute (NCI)42
进行中(未招募)
2 期
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate CancerStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8NCT04253483Rutgers, The State University of New Jersey14
Unknown
2 期
A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate CancerCarcinoma of the ProstateNCT01890096Sunnybrook Health Sciences Centre174
招募中
不适用
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaProstate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8NCT04945642Jonsson Comprehensive Cancer Center52
已完成
2 期
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerProstate CancerNCT00091390Radiation Therapy Oncology Group129
